In today's AFR there is a
piece on Cellestis which includes
Those in favour of the bid have queried whether the online poll could be manipulated and note that the results are not audited.
As Cellestis has made
no attempt to gauge shareholder opinion on the deal and have no evidence of manipulation their opinion is neither independent or expert. However, when it comes to the unpublished Independent Expert Valuation
The talk is that the opinion will show that the $3.55 a share bid is at the upper end - or, as the bulls are suggesting - above the independent expert's valuation range.
Once again shareholders are treated like the proverbial mushrooms.
